. 2024 Apr 23;22(4):e8753. doi: 10.2903/j.efsa.2024.8753

TABLE 2.

Summary of the acute probabilistic risk assessment results.

Active substance	Middle bound of the percentage of individual‐days exceeding the ARfD ^h
	Adults		Other children		Toddlers
	Min ^a	Max ^b	Min ^c	Max ^d	Min ^e	Max ^f
Abamectin	0.0000	0.0000	0.0000	0.0010	0.0002	0.0014
Acetamiprid	0.0000	0.0009	0.0006	0.0029	0.0009	0.0063
Carbaryl	0.0000	0.0000	0.0000	0.0014	0.0000	0.0027
Carbendazim	0.0000	0.0028	0.0000	0.0024	0.0000	0.0041
Carbofuran	0.0011	0.0177	0.0015	0.0120	0.0010	0.0114
Carbosulfan	0.0000	0.0000	0.0000	0.0002	0.0000	0.0002
Chlormequat chloride	0.0000	0.0004	0.0000	0.0010	0.0007	0.0014
Chlorothalonil	0.0000	0.0008	0.0000	0.0004	0.0000	0.0000
Chlorpropham	0.0003	0.0037	0.0015	0.0087	0.0022	0.0155
Cyhalothrin, gamma‐	0.0009	0.0083	0.0086	0.0362	0.0263	0.0439
Cyhalothrin, lambda‐	0.0000	0.0027	0.0015	0.0070	0.0062	0.0119
Cypermethrin, sum	0.0106	0.0644	0.0187	0.0511	0.0265	0.0779
Cypermethrin, alpha‐	0.1155	0.3675	0.1580	0.2738	0.2211	0.3124
Cypermethrin, beta‐	0.0808	0.2849	0.1193	0.2136	0.1713	0.2385
Cypermethrin, zeta‐	0.0000	0.0000	0.0000	0.0000	0.0000	0.0009
Deltamethrin, cis‐	0.0000	0.0000	0.0000	0.0009	0.0000	0.0026
Esfenvalerate	0.0000	0.0000	0.0000	0.0002	0.0000	0.0004
Ethephon	0.0019	0.0088	0.0051	0.0291	0.0193	0.0806
Flonicamid	0.0000	0.0008	0.0000	0.0033	0.0006	0.0028
Fluazifop‐P	0.0000	0.0000	0.0000	0.0002	0.0000	0.0002
Formetanate hydrochloride	0.0000	0.0007	0.0000	0.0018	0.0002	0.0022
Fosthiazate	0.0000	0.0000	0.0000	0.0001	0.0000	0.0005
Glufosinate‐ammonium	0.0000	0.0000	0.0000	0.0014	0.0003	0.0016
Imazalil	0.0000	0.0198	0.0000	0.0093	0.0024	0.0345
Indoxacarb	0.0000	0.0036	0.0006	0.0050	0.0012	0.0051
Mancozeb	0.0000	0.0000	0.0010	0.0077	0.0044	0.0105
Maneb	0.0000	0.0000	0.0000	0.0030	0.0009	0.0049
Metiram	0.0147	0.0693	0.0978	0.2010	0.1574	0.2668
Thiram	0.0127	0.0579	0.0837	0.1736	0.1363	0.2312
Ziram	0.0010	0.0058	0.0109	0.0365	0.0259	0.0480
Methiocarb	0.0002	0.0047	0.0001	0.0007	0.0000	0.0011
Methomyl	0.0000	0.0000	0.0000	0.0001	0.0000	0.0001
Oxamyl	0.0020	0.0265	0.0014	0.0291	0.0020	0.0393
Phosmet	0.0064	0.0972	0.0206	0.1142	0.0382	0.1927
Prochloraz	0.0000	0.0009	0.0000	0.0306	0.0018	0.0037
Propiconazole	0.0000	0.0000	0.0000	0.0000	0.0000	0.0007
Propineb	0.0000	0.0038	0.0070	0.0264	0.0169	0.0368
Pyraclostrobin	0.0000	0.0000	0.0000	0.0008	0.0000	0.0000
Tebuconazole	0.0000	0.0019	0.0000	0.0018	0.0000	0.0037
Thiabendazole	0.0000	0.0049	0.0000	0.0249	0.0039	0.0126
Thiophanate‐methyl	0.0000	0.0009	0.0000	0.0022	0.0005	0.0016
Acephate ^g	0.0000	0.0000	0.0000	0.0005	0.0000	0.0001
Chlorpyrifos ^g	0.0000	0.0018	0.0009	0.0058	0.0029	0.0081
Dichlorvos ^g	0.0000	0.0000	0.0000	0.0002	0.0000	0.0004
Dimethoate ^g	0.0085	0.0692	0.0309	0.1431	0.0567	0.1457
Diniconazole ^g	0.0000	0.0016	0.0000	0.0023	0.0000	0.0011
Diniconazole‐M ^g	0.0000	0.0017	0.0000	0.0024	0.0000	0.0008
Furathiocarb ^g	0.0000	0.0000	0.0000	0.0002	0.0000	0.0002
Heptachlor ^g	0.0000	0.0010	0.0000	0.0005	0.0000	0.0005
Hexachlorocyclohexane (HCH), beta‐isomer ^g	0.0000	0.0007	0.0001	0.0007	0.0001	0.0010
Permethrin ^g	0.0000	0.0033	0.0000	0.0025	0.0000	0.0033
Triazophos ^g	0.0000	0.0000	0.0000	0.0002	0.0000	0.0002

^{^a}

Lowest estimated probability of exceeding the ARfD among the 15 adult populations.

^{^b}

Highest estimated probability of exceeding the ARfD among the 15 adult populations.

^{^c}

Lowest estimated probability of exceeding the ARfD among the 10 child populations.

^{^d}

Highest estimated probability of exceeding the ARfD among the 10 child populations.

^{^e}

Lowest estimated probability of exceeding the ARfD among the 5 toddler populations.

^{^f}

Highest estimated probability of exceeding the ARfD among the 5 toddler populations.

^{^g}

Active substance with a tentative ARfD.

^{^h}

Even if the estimated probability is 0.0000% by the model, it does not mean the true probability on the real population is 0. Therefore, the probability should be considered close to zero.